medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2020, Number 2

<< Back Next >>

Rev Latin Infect Pediatr 2020; 33 (2)

Treatment with intraventricular linezolid plus intravenous in a pediatric patient with vancomycin-resistant Enterococcus faecium ventriculitis

Aguilar GNE, Pérez MSN, Vargas VTM, Chávez EJM, González SN

Language: Spanish
References: 13
Page: 92-96
PDF size: 150.92 Kb.


ABSTRACT

Ventriculitis is a serious complication observed after neurosurgical procedures and is associated in most cases with the presence of external ventricular drainage devices. The main etiologic agents are Gram positive microorganisms such as Staphylococcus epidermidis and Staphylococcus aureus, however, an increase in Enterococcus spp. Infections has now been observed. in the hospital setting, associated with different patterns of antimicrobial resistance. The emergence of vancomycin-resistant Enterococcal (ERV) infections in pediatrics has become a therapeutic challenge and is associated with high mortality.


REFERENCES

  1. Irfan S, Qamar S. A case report on isolation of linezolid and vancomycin-resistant Enterococcus faecium species from cerebrospinal fluid of a patient suffering from ventriculoperitoneal shunt-associated meningitis. Cureus. 2019; 11 (9): 1-4.

  2. Humphreys H, Jenks J. Surveillance and management of ventriculitis following neurosurgery. J Hosp Infect. 2015; 89 (4): 281-286.

  3. Sahin A, Dalgic N. Intraventricular plus intravenous tigecycline for the treatment of daptomycin nonsusceptible vancomycin-resistant enterococci in an infant with ventriculoperitoneal shunt infection. World Neurosurg. 2019; 130: 470-473.

  4. Lich B, Conner A, Burks J, Glenn C, Sughrue M. Intrathecal/ intraventricular linezolid in multidrug-resistant Enterococcus faecalis ventriculitis. J Neurol Surg Rep. 2016; 77: 160-161.

  5. Raza T, Ullah SR, Mehmood K, Andleeb S. Vancomycin resistant enterococci: a brief review. J Pak Med Assoc. 2018; 68 (5): 767-772.

  6. Sood S, Malhotra M, Das BK, Kapil A. Enterococcal infections & antimicrobial resistance. Indian J Med Res. 2008; 128: 111-121.

  7. Wang G, Yu F, Lin H, Murugesan K, Huang W, Hoss AG et al. Evolution and mutations predisposing to daptomycin resistance in vancomycin-resistant Enterococcus faecium ST736 strains. PLoS One. 2018; 13: e0209785.

  8. Jaspan H, Brothers A, Campbell A, McGuire J, Browd S, Manley T et al. Multidrug-resistant Enterococcus faecium meningitis in a toddler. Pediatr Infect Dis J. 2010; 29 (4): 379-381.

  9. Tunkel A, Hasbun R, Bhimraj A, Byers K, Kaplan S, Scheld W, Van de Beek D et al. Infectious diseases Society of America’s Clinical practice guidelines for healthcareassociated ventriculitis and meningitis. Clin Infect Dis. 2017; 64: 701-706.

  10. Patel T, Lewis M, Nielsley M, Chowdhury M. Postneurosurgical central nervous system infection due to Enterococcus faecalis successfully treated witj intraventricular vancomycin. Infect Dis Clin Pract. 2016; 24: 174-176.

  11. Quinn A, Parada J, Belmares J, O’Keefe J. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection. Ann Pharmacother. 2005; 39 (5): 949.

  12. Chiappini E, Conti C, Galli L, Martino M. Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review. Clin Ther. 2010; 32 (1): 1-23.

  13. Myrianthefs P, Markantonis S, Vlachos K, Anagnostaki M, Boutzouka E, Panidis D et al. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother. 2006; 50 (12): 3971- 3976.




2020     |     www.medigraphic.com